SG11201702494UA - Control system for control of distribution of medication - Google Patents

Control system for control of distribution of medication

Info

Publication number
SG11201702494UA
SG11201702494UA SG11201702494UA SG11201702494UA SG11201702494UA SG 11201702494U A SG11201702494U A SG 11201702494UA SG 11201702494U A SG11201702494U A SG 11201702494UA SG 11201702494U A SG11201702494U A SG 11201702494UA SG 11201702494U A SG11201702494U A SG 11201702494UA
Authority
SG
Singapore
Prior art keywords
control
medication
distribution
control system
Prior art date
Application number
SG11201702494UA
Other languages
English (en)
Inventor
Richard Alistair Balfour Stewart
Anthony Clarke
Original Assignee
Zogenix Internat Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54884082&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201702494U(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zogenix Internat Ltd filed Critical Zogenix Internat Ltd
Publication of SG11201702494UA publication Critical patent/SG11201702494UA/en

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/13—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered from dispensers
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F16/00—Information retrieval; Database structures therefor; File system structures therefor
    • G06F16/20—Information retrieval; Database structures therefor; File system structures therefor of structured data, e.g. relational data
    • G06F16/24—Querying
    • G06F16/245—Query processing
    • G06F16/2457—Query processing with adaptation to user needs
    • G06F16/24573—Query processing with adaptation to user needs using data annotations, e.g. user-defined metadata
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C10/00—Computational theoretical chemistry, i.e. ICT specially adapted for theoretical aspects of quantum chemistry, molecular mechanics, molecular dynamics or the like
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/70—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mental therapies, e.g. psychological therapy or autogenous training
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/20—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Public Health (AREA)
  • Theoretical Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Business, Economics & Management (AREA)
  • Business, Economics & Management (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Databases & Information Systems (AREA)
  • Data Mining & Analysis (AREA)
  • Computational Linguistics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Library & Information Science (AREA)
  • Psychiatry (AREA)
  • Developmental Disabilities (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychology (AREA)
  • Social Psychology (AREA)
  • Computing Systems (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG11201702494UA 2014-09-29 2015-09-28 Control system for control of distribution of medication SG11201702494UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462056836P 2014-09-29 2014-09-29
PCT/IB2015/002081 WO2016051271A1 (en) 2014-09-29 2015-09-28 Control system for control of distribution of medication

Publications (1)

Publication Number Publication Date
SG11201702494UA true SG11201702494UA (en) 2017-04-27

Family

ID=54884082

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201702494UA SG11201702494UA (en) 2014-09-29 2015-09-28 Control system for control of distribution of medication

Country Status (16)

Country Link
US (3) US10452815B2 (pt)
EP (2) EP3961640A1 (pt)
JP (2) JP6774402B2 (pt)
KR (1) KR102245345B1 (pt)
CN (1) CN107111673B (pt)
AU (2) AU2015326472B2 (pt)
BR (1) BR112017006219A8 (pt)
CA (1) CA2962367A1 (pt)
IL (2) IL251360B (pt)
MX (1) MX2017004065A (pt)
NZ (2) NZ730560A (pt)
RU (1) RU2704749C2 (pt)
SA (1) SA517381207B1 (pt)
SG (1) SG11201702494UA (pt)
WO (1) WO2016051271A1 (pt)
ZA (1) ZA201705078B (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6893213B2 (ja) 2015-12-22 2021-06-23 ゾゲニクス インターナショナル リミテッド フェンフルラミン組成物およびその調製法
JP2019507111A (ja) 2015-12-22 2019-03-14 ゾゲニクス インターナショナル リミテッド 代謝抵抗性フェンフルラミン類縁体およびその使用法
CA3032996A1 (en) 2016-08-24 2018-03-01 Zogenix International Limited Formulation for inhibiting formation of 5-ht 2b agonists and methods of using same
US20180075558A1 (en) * 2016-09-12 2018-03-15 National Health Coalition, Inc. Processing Pharmaceutical Prescriptions in Real Time Using a Clinical Analytical Message Data File
US10313422B2 (en) * 2016-10-17 2019-06-04 Hitachi, Ltd. Controlling a device based on log and sensor data
US10682317B2 (en) 2017-09-26 2020-06-16 Zogenix International Limited Ketogenic diet compatible fenfluramine formulation
WO2019140432A1 (en) * 2018-01-15 2019-07-18 Hygieia Health Co., Limited Systems, methods, compositions and devices for personalized nutrition formulation and delivery system
US10599922B2 (en) * 2018-01-25 2020-03-24 X Development Llc Fish biomass, shape, and size determination
CN108717876B (zh) * 2018-05-11 2022-05-20 大连诺道认知医学技术有限公司 一种基于指定药物构建给药数据库的方法及装置
EP3790537A1 (en) 2018-05-11 2021-03-17 Zogenix International Limited Compositions and methods for treating seizure-induced sudden death
CN108766587B (zh) * 2018-05-11 2022-05-03 北京诺道认知医学科技有限公司 一种基于指定药物构建给药数据库的方法及装置
US11227685B2 (en) 2018-06-15 2022-01-18 Xact Laboratories, LLC System and method for laboratory-based authorization of genetic testing
US11398312B2 (en) 2018-06-15 2022-07-26 Xact Laboratories, LLC Preventing the fill of ineffective or under-effective medications through integration of genetic efficacy testing results with legacy electronic patient records
US11527331B2 (en) 2018-06-15 2022-12-13 Xact Laboratories, LLC System and method for determining the effectiveness of medications using genetics
US11380424B2 (en) 2018-06-15 2022-07-05 Xact Laboratories Llc System and method for genetic based efficacy testing
US11749393B2 (en) * 2019-05-31 2023-09-05 Becton, Dickinson And Company Systems, apparatuses and methods for capturing images of medical condition management events and related equipment with smartphone and related app that processes images to reduce medical errors
WO2020256713A1 (en) * 2019-06-19 2020-12-24 Hewlett-Packard Development Company, L.P. Using medical test results for medical supply
US11468320B1 (en) 2019-07-31 2022-10-11 Express Scripts Strategic Development, Inc. Methods and systems for predicting prescription directions using machine learning algorithm
US11510614B1 (en) 2019-12-02 2022-11-29 Express Scripts Strategic Development, Inc. Wearable devices and systems for prescription adherence
US11612574B2 (en) 2020-07-17 2023-03-28 Zogenix International Limited Method of treating patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
WO2023084479A2 (en) * 2021-11-15 2023-05-19 Tech Pharmacy Services, Llc Cyber protection for pharmaceutical dispensing systems
WO2023178288A1 (en) 2022-03-17 2023-09-21 Azora Therapeutics, Inc. Companion diagnostics and strategies for treatment with an aryl hydrocarbon receptor agonist compound

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US779717A (en) 1904-10-03 1905-01-10 Frank Klepetko Roasting-furnace.
NL270984A (pt) 1960-11-05
US3117160A (en) 1961-07-27 1964-01-07 Pfizer & Co C Aralkylamines
GB1254332A (en) 1969-02-27 1971-11-17 Science Union & Cie Amino acids and their derivatives and processes for preparing them
DE3717434C1 (de) 1987-05-23 1988-09-15 Degussa Verfahren zur Herstellung von m-Trifluormethylphenylacetonitril
JPH07225800A (ja) * 1994-02-10 1995-08-22 Toshiba Corp 医療機関用診療支援装置
ATE199829T1 (de) 1994-06-03 2001-04-15 Thejmde Trust Meta substituierte arylalkylamine und therapeutische und diagnostische verwendung davon
IT1298349B1 (it) 1996-05-29 2000-01-05 Alfa Chem Ital Processo per la produzione di 1 - (3-trifluorometil) fenil-propan- 2-one intermedio nella sintesi della fenfluramina
IT1292885B1 (it) 1997-04-28 1999-02-11 Alfa Chem Ital Processo per la produzione degli isomeri (r) ed (s)- alfa -metil-3- (trifluorometil)benzene-etanamina.
US6045501A (en) 1998-08-28 2000-04-04 Celgene Corporation Methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug
CA2355293C (en) 1998-12-23 2005-08-16 Orphan Medical, Inc. Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
US7124031B1 (en) 2000-05-11 2006-10-17 Medco Health Solutions, Inc. System for monitoring regulation of pharmaceuticals from data structure of medical and labortory records
WO2002006826A1 (en) * 2000-07-17 2002-01-24 Opt-E-Scrip, Inc. Single-patient drug trials used with accumulated database
US6315720B1 (en) 2000-10-23 2001-11-13 Celgene Corporation Methods for delivering a drug to a patient while avoiding the occurrence of an adverse side effect known or suspected of being caused by the drug
US6737042B2 (en) 2001-05-24 2004-05-18 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
AUPR732601A0 (en) 2001-08-28 2001-09-20 Polychip Pharmaceuticals Pty Ltd Methods for the synthesis of amines such as ephedrine and inter mediates
NZ534757A (en) 2002-03-12 2006-07-28 Merck & Co Inc Substituted amides
US7668730B2 (en) 2002-12-17 2010-02-23 JPI Commercial, LLC. Sensitive drug distribution system and method
US20050260610A1 (en) 2004-05-20 2005-11-24 Kurtz Richard E Method for diagnosing and prescribing a regimen of therapy for human health risk
US9820658B2 (en) * 2006-06-30 2017-11-21 Bao Q. Tran Systems and methods for providing interoperability among healthcare devices
AU2006225980A1 (en) * 2005-03-21 2006-09-28 Health-Smart Limited System for continuous blood pressure monitoring
EP1904630A4 (en) * 2005-06-16 2009-10-21 Bionomics Ltd METHODS OF TREATING AND DIAGNOSING EPILEPSY BY DETECTING MUTATIONS OF THE SCN1A GENE
US8109891B2 (en) 2005-09-19 2012-02-07 Biolert Ltd Device and method for detecting an epileptic event
US7464114B2 (en) * 2005-09-27 2008-12-09 International Business Machines Corporation Method and apparatus to capture and transmit dense diagnostic data of a file system
CA3060475A1 (en) * 2005-11-29 2007-06-07 Children's Hospital Medical Center Optimization and individualization of medication selection and dosing
US7592461B2 (en) 2005-12-21 2009-09-22 Bristol-Myers Squibb Company Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
WO2007079181A2 (en) 2005-12-28 2007-07-12 Neurovista Corporation Methods and systems for recommending an action to a patient for managing epilepsy and other neurological disorders
AU2007213069B2 (en) * 2006-02-06 2010-12-23 Novartis Ag Combination of organic compounds
WO2007130491A2 (en) * 2006-05-02 2007-11-15 Proteus Biomedical, Inc. Patient customized therapeutic regimens
KR200428932Y1 (ko) * 2006-06-28 2006-10-16 조점섭 1회용 각질 제거장치
EP2053961A4 (en) * 2006-08-09 2013-05-01 Biogen Idec Inc METHOD FOR DISPENSING A MEDICAMENT
EP2062588A4 (en) * 2006-08-24 2011-06-08 Kirin Holdings Kk COMPOSITION FOR IMPROVING SKIN CONDITION
EP2115540A4 (en) * 2007-01-31 2011-02-02 Quintiles Transnat Corp Inc METHOD AND SYSTEMS FOR ASSIGNING REPRESENTATIVE ELEMENTS TO LOCATIONS IN CLINICAL ATTEMPTS
DE102007025581A1 (de) * 2007-06-01 2008-12-04 Mettler-Toledo (Albstadt) Gmbh Verfahren zum Wiegen eines Wägegutes und Waage zur Durchführung des Verfahrens
US8140186B2 (en) * 2007-06-19 2012-03-20 Omnicell, Inc. Bin allocation systems, methods, and devices
US20090017169A1 (en) * 2007-07-11 2009-01-15 Assaad Kimberly Nicole Method for making hard pretzels that effectively absorb seasoning slurry
JP2011529923A (ja) * 2008-08-06 2011-12-15 ゴスフォース センター（ホールディングス）プロプライエタリー リミテッド 精神障害（ｐｓｙｃｈｉａｔｒｉｃｄｉｓｏｒｄｅｒ）を治療するための組成物および方法
US8386274B1 (en) * 2008-09-17 2013-02-26 Mckesson Financial Holdings Limited Systems and methods for a prescription safety network utilizing eligibility verification transactions
TWI503101B (zh) * 2008-12-15 2015-10-11 Proteus Digital Health Inc 與身體有關的接收器及其方法
JP2012520130A (ja) * 2009-03-09 2012-09-06 セルジーン コーポレーション 薬に禁忌を示すであろう患者による薬へのアクセスを制限しながら患者へ薬を引き渡すための装置、及びその使用方法
WO2010124137A1 (en) * 2009-04-22 2010-10-28 Millennium Pharmacy Systems, Inc. Pharmacy management and administration with bedside real-time medical event data collection
CA3000256A1 (en) * 2010-03-09 2011-09-15 Perceptimed, Inc. Medication verification and dispensing
WO2011119227A2 (en) * 2010-03-25 2011-09-29 Columbia Northwest Pharmaceuticals, Llc Compositions for the treatment of central nervous system disorders including depression employing novel drug combination therapy to reduce suicidality in patients
JP2011221623A (ja) * 2010-04-06 2011-11-04 Kakimori Suri 在宅診療支援システム及び方法
EP2399513B1 (en) * 2010-06-23 2017-01-04 Qatar University Qstp-B System for non-invasive automated monitoring, detection, analysis, characterisation, prediction or prevention of seizures and movement disorder symptoms
AU2011296003B2 (en) * 2010-09-01 2015-11-12 Arena Pharmaceuticals, Inc. Modified-release dosage forms of 5-HT2C agonist useful for weight management
RU103209U1 (ru) * 2010-10-29 2011-03-27 Общество С Ограниченной Ответственностью "Правовое Сопровождение Бизнеса" Клиническая информационная система
US8796661B2 (en) * 2010-11-01 2014-08-05 Micron Technology, Inc. Nonvolatile memory cells and methods of forming nonvolatile memory cell
JP5693325B2 (ja) * 2011-03-29 2015-04-01 小林クリエイト株式会社 健診結果出力システム及び健診結果出力プログラム
GB201111712D0 (en) 2011-07-08 2011-08-24 Gosforth Ct Holdings Pty Ltd Pharmaceutical compositions
US20140348966A1 (en) * 2011-12-22 2014-11-27 Onesmo B. Balemba Garcinia buchananii baker compounds, compositions and related methods
US20130218586A1 (en) 2012-02-21 2013-08-22 Frederic J. Huser Methods and elements for identifying the appropriate patient populations who can safely use prescription chronic care drugs that are switched to an over-the-counter regulatory status
JP6075973B2 (ja) 2012-06-04 2017-02-08 富士通株式会社 健康状態判定装置およびその作動方法
WO2014106825A2 (en) * 2013-01-06 2014-07-10 Jonathan Rabinowitz Methods and devices for identifying improper medical reporting
US9549909B2 (en) 2013-05-03 2017-01-24 The Katholieke Universiteit Leuven Method for the treatment of dravet syndrome
CN103886415A (zh) * 2014-03-25 2014-06-25 北京蝶禾谊安信息技术有限公司 药品管理方法和装置
EP3170807B1 (en) 2015-11-23 2019-12-11 Frau Pharma S.r.l. New method for synthesis of fenfluramine

Also Published As

Publication number Publication date
CN107111673A (zh) 2017-08-29
AU2015326472A1 (en) 2017-04-13
KR102245345B1 (ko) 2021-04-28
IL251360A0 (en) 2017-05-29
US20160092652A1 (en) 2016-03-31
IL251360B (en) 2020-10-29
US10452815B2 (en) 2019-10-22
RU2704749C2 (ru) 2019-10-30
AU2020202655A1 (en) 2020-05-14
ZA201705078B (en) 2019-07-31
NZ730560A (en) 2020-05-29
EP3201808B1 (en) 2021-10-20
JP2021007038A (ja) 2021-01-21
CN107111673B (zh) 2021-03-23
SA517381207B1 (ar) 2020-06-28
RU2017110222A (ru) 2018-11-08
JP2017528849A (ja) 2017-09-28
EP3961640A1 (en) 2022-03-02
BR112017006219A8 (pt) 2023-02-14
NZ762886A (en) 2022-02-25
AU2015326472B2 (en) 2020-05-28
JP6774402B2 (ja) 2020-10-21
IL277505A (en) 2020-11-30
BR112017006219A2 (pt) 2018-03-13
MX2017004065A (es) 2017-07-24
US10950331B2 (en) 2021-03-16
EP3201808A1 (en) 2017-08-09
RU2017110222A3 (pt) 2018-11-08
US20200051686A1 (en) 2020-02-13
US20210158920A1 (en) 2021-05-27
CA2962367A1 (en) 2016-04-07
KR20170063851A (ko) 2017-06-08
WO2016051271A1 (en) 2016-04-07
IL277505B (en) 2022-03-01

Similar Documents

Publication Publication Date Title
IL277505B (en) A control system for controlling the distribution of periods
PT3139986T (pt) Sistema para administração de gás terapêutico
GB2533027B (en) Control system
PL3134152T3 (pl) Układ bezpiecznej strzykawki
GB201410330D0 (en) Control system
EP3114980A4 (en) Control method for medical system
EP3017840A4 (en) LOCATION CONTROL SYSTEM
GB201506508D0 (en) Path control system
GB201400153D0 (en) Enfine fuel control system
GB201513967D0 (en) Control system
IL249254A0 (en) Gene expression system
GB2540492B (en) Control of power distribution system
GB201607515D0 (en) Height of cut control system
GB2538577B (en) Control system
GB2525383B (en) Feature control system
GB201415192D0 (en) Cruise control
GB2542364B (en) Control system
GB2534886B (en) Control system
GB201520364D0 (en) Control system
HUE057405T2 (hu) Vezérlõrendszer
GB2542793B (en) Control system
EP3197406C0 (en) TEMPERATURE REGULATION SYSTEM
GB2559681B (en) Control system
GB201520986D0 (en) Control system
GB201413280D0 (en) Distributed control system